Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-06

FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals’ supplemental application for Bupropion Hydrochloride (SR). The approval updates the labeling for the sustained-release gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion HCl (SR) (Bupropion hydrochloride sustained-release)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (SR) (BUPROPION HYDROCHLORIDE)